INLEXZO is FDA approved. Here is how it works! #bladdercancer #INLEXZO #TAR200 #fightcancer #johnsonandjohnson

Sunrise 2 was recently stopped based on the IDMC recommendation as TAR-200 + Cetrelimab didn't show superiority over chemoradiation. But SR4 still ongoing. And T0 rates (also of other treatments) raise the hope for potential #bladdersparing approaches! #TAR200 #MIBC